737797-18-1

Usage

InChI:InChI=1/C7H5Cl2.ClH.Zn/c1-5-2-3-6(8)7(9)4-5;;/h2-4H,1H2;1H;/q;;+1/p-1/rC7H5Cl3Zn/c8-6-2-1-5(4-11-10)3-7(6)9/h1-3H,4H2

Upstream product

• 102-47-6 3,4-Dichlorophenylmethyl chloride 
• 10139-47-6 zinc(II) iodide 
• 7440-66-6 zinc 

Downstream Products

• 851546-73-1 2-(3,4-Dichlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h]quinoline-4-carboxylic acid 
• 851547-58-5 3-(3,4-dichlorophenyl)-2-oxopropyl acetate 
• 33107-81-2 1-chloro-3-(3,4-dichlorophenyl)propan-2-one 

Relevant academic research and scientific papers

A study of Negishi cross-coupling reactions with benzylzinc halides to prepare original 3-ethoxypyrazoles

The Negishi palladium-catalyzed cross-coupling reaction between 3-ethoxy-4-iodo-1H-pyrazole and various benzylzinc halides was extensively studied. Using simplified, robust, and optimized reaction conditions, a series of electron-poor benzylzinc halides w

Methods and compositions for selectin inhibition

The present invention relates to the field of anti-inflammatory substances, and more particularly to novel compounds that act as antagonists of the mammalian adhesion proteins known as selectins. In some embodiments, methods for treating selectin mediated disorders are provided which include administration of compound of Formula I: wherein the constituent variables are defined herein.